对“SARS-CoV-2 的神经侵袭潜力可能在 COVID-19 患者呼吸衰竭中起作用”一文的评论的回应。
Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".
机构信息
Department of Histology and Embryology, College of Basic Medical Sciences, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, China.
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Science, Beijing, China.
出版信息
J Med Virol. 2020 Jul;92(7):707-709. doi: 10.1002/jmv.25824. Epub 2020 Apr 10.
Abstract
In a recent review, we have suggested a neuroinvasive potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its possible role in the causation of acute respiratory failure of coronavirus disease 2019 (COVID-19) patients (J Med Viol doi: 10.1002/jmv.25728), based upon the clinical and experimental data available on the past SARS-CoV-1 and the recent SARS-CoV-2 pandemic. In this article, we provide new evidence recently reported regarding the neurotropic potential of SARS-CoV-2 and respond to several comments on our previously published article. In addition, we also discuss the peculiar manifestations of respiratory failure in COVID-19 patients and the possible involvement of nervous system.
摘要
在最近的一篇综述中，我们根据过去 SARS-CoV-1 和最近 SARS-CoV-2 大流行期间现有的临床和实验数据，提出了严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）具有神经侵袭性的可能性及其在导致 2019 年冠状病毒病（COVID-19）患者急性呼吸衰竭中的可能作用（J Med Viol doi: 10.1002/jmv.25728）。在本文中，我们提供了最近关于 SARS-CoV-2 神经嗜性潜力的新证据，并对我们之前发表的文章的几个评论做出了回应。此外，我们还讨论了 COVID-19 患者呼吸衰竭的特殊表现以及神经系统可能的参与。
相似文献
1
Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".
J Med Virol. 2020 Jul;92(7):707-709. doi: 10.1002/jmv.25824. Epub 2020 Apr 10.
2
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
3
Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".
J Med Virol. 2020 Jul;92(7):703-704. doi: 10.1002/jmv.25960. Epub 2020 May 22.
4
Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
ACS Chem Neurosci. 2020 Aug 19;11(16):2416-2421. doi: 10.1021/acschemneuro.0c00349. Epub 2020 Aug 11.
5
Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
ASN Neuro. 2020 Jan-Dec;12:1759091420954960. doi: 10.1177/1759091420954960.
6
The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
J Med Virol. 2020 Jul;92(7):786-790. doi: 10.1002/jmv.25918. Epub 2020 Apr 29.
7
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28.
8
The involvement of the central nervous system in patients with COVID-19.
Rev Neurosci. 2020 May 26;31(4):453-456. doi: 10.1515/revneuro-2020-0026.
9
Pangolins Harbor SARS-CoV-2-Related Coronaviruses.
Trends Microbiol. 2020 Jul;28(7):515-517. doi: 10.1016/j.tim.2020.04.001. Epub 2020 Apr 6.
10
Managing neonates with respiratory failure due to SARS-CoV-2.
Lancet Child Adolesc Health. 2020 Apr;4(4):e8. doi: 10.1016/S2352-4642(20)30073-0. Epub 2020 Mar 6.
引用本文的文献
1
Refueling the post COVID-19 brain: potential role of ketogenic medium chain triglyceride supplementation: an hypothesis.
Front Nutr. 2023 Jun 21;10:1126534. doi: 10.3389/fnut.2023.1126534. eCollection 2023.
2
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy.
Pharmaceutics. 2023 May 22;15(5):1562. doi: 10.3390/pharmaceutics15051562.
3
Association of COVID-19 with Comorbidities: An Update.
ACS Pharmacol Transl Sci. 2023 Feb 27;6(3):334-354. doi: 10.1021/acsptsci.2c00181. eCollection 2023 Mar 10.
4
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise.
Mol Cell Biochem. 2023 Jul;478(7):1533-1559. doi: 10.1007/s11010-022-04610-1. Epub 2022 Nov 21.
5
Neuroprotective Drug Discovery From Phytochemicals and Metabolites for CNS Viral Infection: A Systems Biology Approach With Clinical and Imaging Validation.
Front Neurosci. 2022 Jul 25;16:917867. doi: 10.3389/fnins.2022.917867. eCollection 2022.
6
Influence of traditional Chinese medicines on the metabolism of lopinavir/ritonavir based on UHPLC-MS/MS analysis.
J Pharm Anal. 2022 Apr;12(2):270-277. doi: 10.1016/j.jpha.2021.06.006. Epub 2021 Jun 25.
7
COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality.
Biomed Pharmacother. 2022 Jul;151:113089. doi: 10.1016/j.biopha.2022.113089. Epub 2022 May 8.
8
Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19.
Front Physiol. 2022 Apr 14;13:783251. doi: 10.3389/fphys.2022.783251. eCollection 2022.
9
Exploring the Clinical Utility of Gustatory Dysfunction (GD) as a Triage Symptom Prior to Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the Diagnosis of COVID-19: A Meta-Analysis and Systematic Review.
Life (Basel). 2021 Nov 29;11(12):1315. doi: 10.3390/life11121315.
10
Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).
Sovrem Tekhnologii Med. 2021;12(6):98-108. doi: 10.17691/stm2020.12.6.11. Epub 2020 Dec 28.
本文引用的文献
1
Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2.
J Med Virol. 2020 Jul;92(7):705-706. doi: 10.1002/jmv.25828. Epub 2020 Apr 24.
2
Global approaches for global challenges: The possible support of rehabilitation in the management of COVID-19.
J Med Virol. 2020 Oct;92(10):1739-1740. doi: 10.1002/jmv.25829. Epub 2020 Apr 8.
3
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.
4
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
5
A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan.
N Engl J Med. 2020 Mar 12;382(11):1070-1072. doi: 10.1056/NEJMc2001573. Epub 2020 Feb 12.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4.
J Infect Dis. 2016 Mar 1;213(5):712-22. doi: 10.1093/infdis/jiv499. Epub 2015 Oct 20.
9
Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.
J Virol. 2008 Aug;82(15):7264-75. doi: 10.1128/JVI.00737-08. Epub 2008 May 21.
10
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.
J Virol. 2007 Jan;81(2):813-21. doi: 10.1128/JVI.02012-06. Epub 2006 Nov 1.
Zotero 插件